99
Participants
Start Date
June 30, 2011
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
NT-KO-003
NT-KO-003 is a coated tablet, administered once a day
Charité Universitätsmedizin, Berlin
Klinik und Poliklinik für Neurologie, Münster
Neurologisches Studienzentrum an der Stiftung Deutsche Klinik für Diagnostik GmbH, Wiesbaden
Hospital Germans Trias i Pujol, Badalona
Hospital Clinic i Provincial, Barcelona
Hospital del Mar, Barcelona
Hospital Vall d'Hebrón, Barcelona
Hospital Universitari Josep Trueta, Girona
Hospital Clínico San Carlos, Madrid
Hospital Universitario 12 de Octubre, Madrid
Hospital Universitario La Paz, Madrid
Hospital Universitario La Princesa, Madrid
Hospital Universitario Puerta del Hierro, Madrid
Hospital Regional Universitario Carlos Haya, Málaga
Complexo Hospitalario Universitario de Santiago, Santiago de Compostela
Hospital Universitario La Fe, Valencia
Hospital Xeral Vigo, Vigo
Lead Sponsor
Advancell - Advanced In Vitro Cell Technologies, S.A.
INDUSTRY
Neurotec Pharma
INDUSTRY